A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis. [electronic resource]
Producer: 20170914Description: e117 p. digitalISSN:- 1535-1386
- Animals
- Benzamides -- administration & dosage
- Bone Morphogenetic Protein 2 -- administration & dosage
- Diphenylamine -- administration & dosage
- Disease Models, Animal
- Drug Therapy, Combination
- Female
- Mice
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Neurofibromatosis 1 -- complications
- Osteogenesis -- drug effects
- Pseudarthrosis -- drug therapy
- Recombinant Proteins -- administration & dosage
- Transforming Growth Factor beta -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.